Home > Healthcare > Medical Devices > Therapeutic Devices > Diabetic Retinopathy Market

Diabetic Retinopathy Market Share

Name: Diabetic Retinopathy Market Size : 2019-2025 Industry Share Analysis
Creator: Global Market Insights
License: https://www.gminsights.com/privacy-policy

Report ID: GMI486
Published Date: Apr 2019
Report Format: PDF

Download Free Sample

Diabetic Retinopathy Market Share

Some of the major industry players operative in the diabetic retinopathy market include

Novartis
Regeneron Pharmaceuticals
Genentech
Allergan and Bayer AG
Aerpio Pharmaceuticals
Ampio Pharmaceuticals
BCN Peptides
ThromboGenics
Kowa Company
Alimera Sciences

Mergers, acquisitions and new product launch are some of the strategies that help these players in attaining sustainable market position. Receiving FDA approvals for new products also proves beneficial for company’s growth. For instance, in April 2019, Novartis received approval for brolucizumab, an ophthalmic drug. Thus, receiving approval for new drugs will increase company’s product sales.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of diabetic retinopathy surpassed USD 8 billion in 2018.

The industry share of diabetic retinopathy is forecast to witness 6.9% CAGR from 2019 to 2025.

Rapid technological advancements in ophthalmic surgical procedures coupled with favorable reimbursement policies will support the market demand.

Increasing number of diabetic patient base, rising demand for surgical instruments and medications, and a sophisticated healthcare infrastructure is propelling the regional trends. As per the study, the regional share stood at USD 3 billion in 2018.

The increasing prevalence of diabetes in this age group due to sedentary lifestyles and unhealthy diet is boosting the segment growth. As per Global Market Insights, Inc. the segment will register a CAGR of 7.2% over 2019-2025.